Essbio S.A.

SNSE:ESSBIO-C Stock Report

Market Cap: CL$264.2b

Essbio Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Essbio.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Water Utilities earnings growth10.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Dec 16

Essbio (SNSE:ESSBIO-C) Shareholders Will Want The ROCE Trajectory To Continue

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analysis Article • Sep 04

Is Essbio (SNSE:ESSBIO-C) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Mar 27

Essbio's (SNSE:ESSBIO-C) Dividend Will Be Reduced To CLP0.2943

Essbio S.A. ( SNSE:ESSBIO-C ) is reducing its dividend from last year's comparable payment to CLP0.2943 on the 23rd of...
Analysis Article • May 21

Investors Appear Satisfied With Essbio S.A.'s (SNSE:ESSBIO-C) Prospects As Shares Rocket 48%

Essbio S.A. ( SNSE:ESSBIO-C ) shareholders have had their patience rewarded with a 48% share price jump in the last...
Analysis Article • Sep 15

We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings

Essbio S.A.'s ( SNSE:ESSBIO-C ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
Analysis Article • May 30

Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Mar 29

A Look At The Intrinsic Value Of Essbio S.A. (SNSE:ESSBIO-C)

How far off is Essbio S.A. ( SNSE:ESSBIO-C ) from its intrinsic value? Using the most recent financial data, we'll take...
Analysis Article • Mar 09

Should You Be Impressed By Essbio's (SNSE:ESSBIO-C) Returns on Capital?

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • Feb 15

Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jan 04

Should Essbio S.A. (SNSE:ESSBIO-C) Focus On Improving This Fundamental Metric?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Analysis Article • Dec 08

Has Essbio (SNSE:ESSBIO-C) Got What It Takes To Become A Multi-Bagger?

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
Analysis Article • Nov 17

Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Essbio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:ESSBIO-C - Analysts future estimates and past financials data (CLP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025255,89033,05032,626110,644N/A
9/30/2025250,91728,32127,212107,457N/A
6/30/2025248,90428,17426,090104,966N/A
3/31/2025247,00927,30230,065106,732N/A
12/31/2024243,36325,94725,319102,482N/A
9/30/2024240,04626,61024,427102,443N/A
6/30/2024237,54729,78129,218106,169N/A
3/31/2024237,00632,24428,410110,127N/A
12/31/2023233,76829,68429,485108,050N/A
9/30/2023235,75525,52633,728109,236N/A
6/30/2023231,95515,63530,957105,102N/A
3/31/2023225,1546,92631,704100,169N/A
12/31/2022218,8557,14930,77294,961N/A
9/30/2022209,5376,94229,13987,647N/A
6/30/2022203,86114,46932,46087,908N/A
3/31/2022197,45520,26727,64181,660N/A
12/31/2021188,89818,46627,04877,548N/A
9/30/2021183,49220,34724,19574,217N/A
6/30/2021178,32719,19521,98270,875N/A
3/31/2021175,47220,12720,84468,509N/A
12/31/2020173,77720,78617,13369,802N/A
9/30/2020171,48321,10723,50179,813N/A
6/30/2020170,23021,04622,72375,818N/A
3/31/2020169,93520,09426,76778,149N/A
12/31/2019169,19320,50831,72077,855N/A
9/30/2019168,47721,139N/A73,913N/A
6/30/2019167,46320,702N/A74,630N/A
3/31/2019163,75820,694N/A75,230N/A
12/31/2018159,27219,259N/A68,611N/A
9/30/2018156,18517,720N/A60,638N/A
6/30/2018153,70119,387N/A56,947N/A
3/31/2018151,90422,260N/A50,551N/A
12/31/2017149,56425,132N/A50,057N/A
9/30/2017149,29827,874N/A46,367N/A
6/30/2017148,07026,884N/A47,472N/A
3/31/2017146,71223,866N/A45,691N/A
12/31/2016147,73123,351N/A44,956N/A
9/30/2016141,45127,218N/A46,721N/A
6/30/2016141,81326,833N/A47,332N/A
3/31/2016142,40626,295N/A51,453N/A
12/31/2015140,12225,176N/A53,715N/A
9/30/2015144,23316,276N/A45,469N/A
6/30/2015141,44716,099N/A43,728N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ESSBIO-C's forecast earnings growth is above the savings rate (5.7%).

Earnings vs Market: Insufficient data to determine if ESSBIO-C's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if ESSBIO-C's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ESSBIO-C's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 20:42
End of Day Share Price 2026/05/06 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Essbio S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.